The brain is one of the body’s most energy-demanding organs, accounting for 2 percent of the body’s weight but consuming 20 ...

First-ever clinical trial exclusively conducted among people with hard-to-treat form of tuberculosis known as pre-extensively ...

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer immunotherapy ...

This article is part of Harvard Medical School’s continuing coverage of medicine, biomedical research, medical education and policy related to the SARS-CoV-2 pandemic and the disease COVID-19.

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer… ...

A new study from investigators at the Benson-Henry Institute for Mind/Body Medicine at Massachusetts General Hospital and Beth Israel Deaconess Medical Center finds that eliciting the relaxation ...

At a glance: New AI tool accurately predicts both overall survival and disease-free survival after colorectal cancer diagnosis. The model uses visual markers on pathology images to glean insights into ...

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long endeavor reached fruition in the form of a new treatment, CASGEVY, approved by ...

The composition of the gut microbiome may affect the likelihood of developing type 2 diabetes, according to the largest and most ethnically and geographically comprehensive study of its kind to date.

For Rogulja, an associate professor of neurobiology in the Blavatnik Institute at Harvard Medical School, an intriguing aspect of sleep is the loss of consciousness and awareness it brings, as the ...

Learning focus areas At its January 2023 meeting, the HMS Educational Policy and Curriculum Committee responded enthusiastically to a presentation by Basu and other faculty and students involved in ...

What the Pandemic Is Teaching Us About the Immune System In the aftermath of the COVID-19 crisis, immunology may be entering a new golden age ...